On CNBC’s “Mad Money Lightning Round,” Jim Cramer sang the praises of Energy Transfer LP (NYSE:ET), which posted better-than-expected earnings for its fourth quarter.
Cramer also mentioned how KKR & Co. Inc. (NYSE:KKR) and Blackstone (NYSE:BX) are having “a big run now.”
“They’re very good, and I think they can make more money than they have,” he added.
KKR and Blackstone have over $550 billion and $1 trillion in assets under management, respectively.
Considering trying out virtual dating RN? We got you. Here are some tips to turn you into a video dating pro — instantly.
On March 26, Weave Living and KKR reported the establishment of a strategic partnership to invest in rental housing assets in South Korea.
Rio Tinto Group (NYSE:RIO) is a “great company to buy here,” Cramer said.
On Feb. 21, Rio Tinto reported full-year FY23 results. Sales revenue declined 3% Y/Y to $54 billion, beating the consensus of $53.9 billion. Underlying EPS decreased 12% Y/Y to $7.25, missing the street view of $7.27.
The “Mad Money” host recommended buying Becton, Dickinson and Company (NYSE:BDX). “The stock has been getting crushed,” he noted.
Are You Taking One of These 9 “Memory Erasing” Prescriptions? [ad]
You may think your memory loss is just a sign of getting older, but one of these 9 drugs could actually be damaging your brain... These 9 prescription drugs have now been linked to Alzheimer's disease diagnoses. If you're over the age of 60, and you're taking even 1 of these 9 drugs, your brain could be at risk. Click here to learn more.
On March 21, Becton Dickinson said it increased production of medical syringes in the U.S. after the FDA recommended not using some China-made syringes as part of its ongoing quality probe.
When asked about California Resources Corporation (NYSE:CRC), he said, “I would rather be in Constellation Energy (NYSE:STZ). If I’m going to be in that, let’s just go right to the source.”
On March 19, California Resources announced the nomination of Christian S. Kendall to its Board of Directors.
e.l.f. Beauty, Inc. (NYSE:ELF) is “amazing,” Cramer said. “I would hold onto that, don’t buy more, and don’t sell.”
If you can’t decide whether to get the 2-in-1 Windows tablet hybrid, traditional laptop, or desktop, we’re here to help.
On March 21, DA Davidson analyst Linda Bolton Weiser maintained e.l.f. Beauty with a Buy and maintained a $220 price target.
Cramer said Pure Storage, Inc. (NASDAQ:PSTG) has just run so much. “I have to advise you to buy some and then wait for a pullback,” he added.
On March 15, Citigroup analyst Asiya Merchant initiated coverage on Pure Storage with a Buy rating and announced a price target of $65.
Samsara Inc. (NYSE:IOT) is the “hottest stock, and it’s going to make money, too, and it’s really good,” Cramer said.
On March 7, Samsara reported better-than-expected fourth-quarter financial results and issued FY25 guidance above estimates. The company posted quarterly revenue of $276.3 million, topping market estimates of $258.306 million.
“A lot of lasers, a lot of optics, a lot of good stuff. Going to make money this year,” Cramer said about Coherent Corp. (NYSE:COHR). He recommended buying some here and then wait for the stock to come down.
On Feb. 5, Coherent reported better-than-expected second-quarter financial results, issued third-quarter guidance and revised FY24 guidance.
Cramer said he likes New Fortress Energy Inc. (NYSE:NFE) and recommended buying the stock. “I think Wes Edens [Founder and CEO] is absolutely terrific at what he does,” he added.
Price Action:
- Shares of Energy Transfer closed at $15.56 on Monday.
- KKR shares gained 1% to close at $100.85.
- Becton Dickinson shares fell 1.9% to settle at $241.67 on Monday.
- Samsara shares gained 3.9% to close at $38.54.
- Rio Tinto shares gained 0.7% to settle at $63.41.
- Coherent fell 1.9% to close at $62.12 on Monday.
- New Fortress Energy shares fell 1% to settle at $29.76.
- California Resources shares gained 1.8% to settle at $53.99 on Monday.
- Pure Storage shares gained 0.9% to close at $52.68 on Monday.
- E.l.f. Beauty shares fell 2.7% to close at $200.04 on Monday.
Read Next: Insiders Buying Greenwich LifeSciences And 2 Other Stocks
Image: Shutterstock
